This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioPharm America
2 days in-person. 2 days virtually.
September 28–29, 2022 | Boston, USAOctober 4–5, 2022 | Virtual

A launchpad for investment and partnerships in biotech

The Startup Springboard is a pitch competition featuring the most innovative startup biotech companies

Apply today to be part of the roster of pitching companies

Startup Springboard taking place at BioPharm America

Wednesday, September 28, 2022 | 3:15 - 5:00 pm
Boston Convention & Exhibition Center

Get your company on the opportunity map

Pitch your breakthroughs and get noticed by top-tier investors, biopharma executives and potential partners. 

Startup Company Criteria

Startup companies that meet the following criteria are encouraged to apply

  • Created in the past three years
  • Has fewer than 10 employees
  • Aggregate financing of 5 million USD or less
  • Developing new therapeutic products, technology platforms, or digital medicine technologies

Fee Structure

  • Pitch fee: USD 195*
  • Discounted BioPharm America rate: USD 495
  • Total pitch package fee: 690

*Qualifying criteria must be met for this rate

Pitch details

  • 5-minute company pitch with 5 slides
  • Judges choice winner will get a ticket to an EBD Group conference of their choice
  • A USD 400 discount to register to BioPharm America
  • A USD 200 discount to enroll in any upcoming EBD Academy Course in 2022


We understand as an early-stage company you face many challenges, including getting in front of the right people. The Startup Springboard is designed to provide you with an affordable opportunity to engage with top-tier investors and other important players in the biotech industry to take your startup to the next level.


Generate interest among top-tier investors and pharma execs through a company pitch


Have conversations with potential investors and partners onsite at BioPharm America


Attain funding, infrastructure, and mentorship

Need help?

Please direct any questions to:

Olivia Guilliana
EBD Group